Latest News & Features
Americas
Immunology-focused Vir Biotechnology and Hong Kong-based WuXi Biologics have become the latest companies to turn their focus to developing treatments for the novel coronavirus. 27 February 2020
Big Pharma
US-based Gilead Sciences has been granted three Chinese patents connected to possible COVID-19 treatment remdesivir, reported He Zhimin, the deputy director of China’s National Intellectual Property Administration. 27 February 2020
Big Pharma
French drugmaker Sanofi is looking to create a new European manufacturer of active pharmaceutical ingredients, amid concerns over dependence on a Chinese manufacturing sector hit by coronavirus. 27 February 2020
Americas
The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation. 25 February 2020
Asia
British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate. 25 February 2020
article
Norton Rose Fulbright has named Gina Shishima as its new US chief operations partner. 24 February 2020
Americas
Gilead Sciences has failed in its efforts to have US government patents covering the use of HIV drugs as pre-exposure prophylaxis invalidated. 21 February 2020
Americas
Genetic sequencing company Illumina is seeking a preliminary injunction to stop its China-based rival BGI from distributing DNA sequencers in the US. 21 February 2020
Big Pharma
Japanese drugmaker Kaneka has accused Irish nutrition company Glanbia of infringing two patents with its ActiQuinol antioxidant products. 20 February 2020
Americas
US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit. 20 February 2020